A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease

Autor: Alexis De Haven Brandon, Paul Workman, Aurélie Mallinger, Elizabeth Fraser, Mark Stubbs, Paul Czodrowski, Andree Blaukat, Richard Schneider, Julian Blagg, Djordje Musil, Melanie Valenti, Daniel Schwarz, Rahul S. Samant, Klaus Schneider, Kai Schiemann, Sharon Gowan, Christina Esdar, Florence I. Raynaud, Suzanne A. Eccles, Robert TePoele, Dennis Waalboer, Gary Box, Dirk Wienke, Oliver Poeschke, Paul A. Clarke, Maria-Jesus Ortiz-Ruiz, Kenneth Burnside Ramsay Ewan, Trevor Clive Dale, Felix Rohdich, Olajumoke Adeniji-Popoola, Will Court
Rok vydání: 2015
Předmět:
Zdroj: Nature chemical biology
ISSN: 1552-4469
1552-4450
Popis: There is unmet need for chemical tools to explore the role of the Mediator complex in human pathologies ranging from cancer to cardiovascular disease. Here we determine that CCT251545, a small-molecule inhibitor of the WNT pathway discovered through cell-based screening, is a potent and selective chemical probe for the human Mediator complex-associated protein kinases CDK8 and CDK19 with >100-fold selectivity over 291 other kinases. X-ray crystallography demonstrates a type 1 binding mode involving insertion of the CDK8 C terminus into the ligand binding site. In contrast to type II inhibitors of CDK8 and CDK19, CCT251545 displays potent cell-based activity. We show that CCT251545 and close analogs alter WNT pathway-regulated gene expression and other on-target effects of modulating CDK8 and CDK19, including expression of genes regulated by STAT1. Consistent with this, we find that phosphorylation of STAT1(SER727) is a biomarker of CDK8 kinase activity in vitro and in vivo. Finally, we demonstrate in vivo activity of CCT251545 in WNT-dependent tumors.
Databáze: OpenAIRE